clotrimazole has been researched along with anandamide in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ekins, S; Harwood, HJ; Hoover, DJ; Lawton, MP; Mankowski, DC; Treadway, JL | 1 |
Kendall, DA; McCulloch, AI; Randall, MD | 1 |
Kendall, DA; Randall, MD | 1 |
3 other study(ies) available for clotrimazole and anandamide
Article | Year |
---|---|
Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitors.
Topics: Amides; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Humans; Indoles; Models, Molecular; Oxidoreductases; Quantitative Structure-Activity Relationship; Sterol 14-Demethylase | 2007 |
Comparative pharmacology of endothelium-derived hyperpolarizing factor and anandamide in rat isolated mesentery.
Topics: Animals; Arachidonic Acids; Biological Factors; Calcium Channel Blockers; Cannabinoid Receptor Modulators; Cannabinoids; Clotrimazole; Dose-Response Relationship, Drug; Endocannabinoids; Enzyme Inhibitors; In Vitro Techniques; Male; Mesenteric Arteries; Muscarinic Agonists; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Polyunsaturated Alkamides; Potassium; Potassium Channel Blockers; Proadifen; Rats; Rats, Wistar; Tetraethylammonium; Vasodilation; Vasodilator Agents | 1997 |
Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation.
Topics: Animals; Arachidonic Acids; Biological Factors; Bradykinin; Calcium Channel Blockers; Cannabinoid Receptor Modulators; Cannabinoids; Clotrimazole; Coronary Vessels; Endocannabinoids; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Piperidines; Polyunsaturated Alkamides; Potassium Channel Blockers; Pyrazoles; Quaternary Ammonium Compounds; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Vasodilation | 1997 |